Tag: HIV prevention


  • US HIV Aid Cuts in Sub-Saharan Africa Risk Global Health Setbacks, Experts Warn

    US HIV Aid Cuts in Sub-Saharan Africa Risk Global Health Setbacks, Experts Warn

    Overview: A shift in US HIV aid and its global implications In the wake of policy changes early in the current administration, U.S. funding for HIV programs in sub-Saharan Africa has faced reductions and restructuring. CIDRAP reports that these moves come after executive actions aimed at reconfiguring foreign-assistance programs and reshaping institutions like USAID. While…

  • US HIV Aid Cuts in Sub-Saharan Africa Pose Global Health Risks, Experts Say

    US HIV Aid Cuts in Sub-Saharan Africa Pose Global Health Risks, Experts Say

    Overview: Why US HIV Aid Cuts Matter The CIDRAP report highlights a looming threat to global health security as the United States scales back funding for HIV programs in sub-Saharan Africa. While foreign aid policies often shift with political winds, reductions in HIV prevention, treatment, and surveillance programs in this region can reverberate far beyond…

  • HIV funding shortfall endangers millions as US aid pause cascades through programs

    HIV funding shortfall endangers millions as US aid pause cascades through programs

    HIV funding shortfall compounds a global health crisis A widening gap in HIV funding is accelerating a health emergency that many communities cannot afford to ignore. With the United States government pausing all foreign assistance in January 2025, life-saving HIV medicines, prevention services, and support programs faced an abrupt and unpredictable disruption. As governments and…

  • HIV funding shortfall worsens crisis as US aid pause undercuts life-saving programs

    HIV funding shortfall worsens crisis as US aid pause undercuts life-saving programs

    HIV funding gaps emerge as a global health crisis deepens The world’s fight against HIV/AIDS faces a troubling hurdle: funding shortfalls at a time of rising need. A combination of stagnant domestic funding, shifting international priorities, and a consequential pause in U.S. foreign assistance since January 2025 has created a chilling effect on the delivery…

  • Ministry Approves Rollout of Lenacapavir, a Long-Acting HIV Prevention Injection

    Ministry Approves Rollout of Lenacapavir, a Long-Acting HIV Prevention Injection

    New Era in HIV Prevention: Lenacapavir Approved for Rollout The Ministry of Health has announced approval for the nationwide rollout of Lenacapavir, a long-acting injectable drug designed to prevent HIV infection. The regimen, administered once every six months, offers a new option for individuals seeking sustained protection, including those who may not consistently use daily…

  • Ministry Approves Long-Acting HIV Prevention Drug Lenacapavir for Rollout

    Ministry Approves Long-Acting HIV Prevention Drug Lenacapavir for Rollout

    National Rollout Set to Begin for Lenacapavir The Ministry of Health has moved to accelerate the deployment of Lenacapavir, a long-acting injectable medication designed to prevent HIV infection. By approving a drug that is administered only twice a year, health officials aim to broaden access to effective prevention and reduce new HIV infections across populations…

  • Ministry Approves Long-Acting HIV Prevention Drug for Rollout

    Ministry Approves Long-Acting HIV Prevention Drug for Rollout

    Move Forward with Lenacapavir: A New Chapter in HIV Prevention The Ministry of Health has officially greenlit the rollout of Lenacapavir, a long-acting preventive treatment designed to reduce HIV infections. The approval marks a significant step forward in public health, offering a new option for people at risk of HIV exposure. Unlike daily pills, Lenacapavir…

  • Promising HIV Vaccine Candidate Launches Phase 1 Clinical Trial

    Promising HIV Vaccine Candidate Launches Phase 1 Clinical Trial

    Overview: A Promising Step Toward HIV Prevention Health researchers have announced the launch of a Phase 1 clinical trial for a promising HIV vaccine candidate. The study represents a cautious but important milestone in the quest to prevent new HIV infections, especially as researchers emphasize safety and immune response in the early stages of development.…

  • Lagos Agency Calls for Vigilance and Responsibility During Yuletide Season

    Lagos Agency Calls for Vigilance and Responsibility During Yuletide Season

    LSACA’s Yuletide Advisory: Why Vigilance Matters As Lagos State enters a period of heightened social activity and increased travel for the festive season, the Lagos State AIDS Control Agency (LSACA) has issued a call for vigilance and responsible behaviour among residents. The advisory comes as gatherings, celebrations, and long-distance travel surge across the metropolis, creating…

  • PrEP Guide: How to Get HIV Prevention Medicine

    PrEP Guide: How to Get HIV Prevention Medicine

    Understanding PrEP and Why It Matters PrEP, or pre-exposure prophylaxis, is a daily or event-based pill regimen that significantly reduces the risk of HIV infection when taken consistently. For many people, PrEP is a powerful tool in a broader prevention strategy that can include condoms, regular testing, and routine medical care. Access should be based…